Allterum Therapeutics, Inc. is a spin-out company out of Fannin Innovation Studios. Allterum is developing an immunotherapy for the treatment of relapsed/refractory T-cell pediatric acute lymphoblastic leukemia, on-track for IND submission in early 2021.

• Lead on two oncology-oriented portfolio technologies (one monoclonal antibody, one small molecule). Identified and developed pre-clinical strategies towards commercializing a therapeutic antibody, including identifying, negotiating with, and managing leading clinicians, consultants, clinical consortia, and contract research organizations• Represented a clinical stage spin-out company at the Biotech Showcase/JPM Partnering Conference• Member of due-diligence team, assessing scientific… Show more • Lead on two oncology-oriented portfolio technologies (one monoclonal antibody, one small molecule). Identified and developed pre-clinical strategies towards commercializing a therapeutic antibody, including identifying, negotiating with, and managing leading clinicians, consultants, clinical consortia, and contract research organizations• Represented a clinical stage spin-out company at the Biotech Showcase/JPM Partnering Conference• Member of due-diligence team, assessing scientific and market validity of potential pipeline assets• Member of staffing and financial allocation team for therapeutics portfolio assets• Member of hiring and recruiting team for new fellows, interns, and lab staff Show less

• Worked as part of management team leading start-up therapeutic technologies and companies founded or co-founded by Fannin Innovation Studio• Performed due diligence on technologies, designed experiments to drive commercialization, analyzed data, managed and assisted in expansion of intellectual property, participated in strategic regulatory decisions, and pursued non-dilutive funding through SBIR and private foundation grant applications. • Assisted in market research, competitive… Show more • Worked as part of management team leading start-up therapeutic technologies and companies founded or co-founded by Fannin Innovation Studio• Performed due diligence on technologies, designed experiments to drive commercialization, analyzed data, managed and assisted in expansion of intellectual property, participated in strategic regulatory decisions, and pursued non-dilutive funding through SBIR and private foundation grant applications. • Assisted in market research, competitive analysis, and business development activities, including outreach Show less

Pulmotect is a clinical-stage spin-out company out of Fannin Innovation Studio. I spent ~20% of time working with Pulmotect, including:• Representing Pulmotect at the Biotech Showcase/JPM Conference, meeting with companies to discuss the technology, potential partnerships, and exit strategies• Identifying and providing recommendations for late-stage clinical trial target populations and final market indications

Completed my Ph.D. in the Department of Molecular and Cell Biology in the lab of Dr. Nicholas Mitsiades. My thesis work primarily focused on investigating transcriptional coregulators and their roles in the progression and maintenance of castration-resistant prostate cancers.Dissertation: Inhibiting Castration-Resistant Prostate Cancer via Targeting Transcriptional Coregulators.

As an intern with the Baylor Licensing Group tech transfer office, I was responsible for completing preliminary reviews of Baylor College of Medicine technologies (including therapeutics and medical devices) in order to establish whether or not intellectual property protections should be pursued. This involved evaluating the technology not only from a patentability perspective, but also with regard to marketability. I also participated in some market analysis, generating an overview of the… Show more As an intern with the Baylor Licensing Group tech transfer office, I was responsible for completing preliminary reviews of Baylor College of Medicine technologies (including therapeutics and medical devices) in order to establish whether or not intellectual property protections should be pursued. This involved evaluating the technology not only from a patentability perspective, but also with regard to marketability. I also participated in some market analysis, generating an overview of the technology for potential licensees. Show less

As an intern with Fannin Innovation Studio, I primarily worked on the feasibility and pitch of a new company, including due diligence, scientific strategy, and development of a business plan.

In charge of culturing and expanding hybridomas for antibody production as well as purification of antibodies and testing by Western blot.

Assist in antibody engineering – from protein expression and immunization of animals to screening and isolating hybridomas to purifying monoclonal antibodies. Responsibilities included immunizing, bleeding mice and testing serum, assisting with hybridoma fusions, capture and sandwich ELISAs, subcloning by limiting dilution, cell culture, protein purification by FPLC, and verification by Western Blot and Coomassie blue stain. Additionally, isolation of mRNA from splenocytes and the subsequent… Show more Assist in antibody engineering – from protein expression and immunization of animals to screening and isolating hybridomas to purifying monoclonal antibodies. Responsibilities included immunizing, bleeding mice and testing serum, assisting with hybridoma fusions, capture and sandwich ELISAs, subcloning by limiting dilution, cell culture, protein purification by FPLC, and verification by Western Blot and Coomassie blue stain. Additionally, isolation of mRNA from splenocytes and the subsequent development and screening of phage display libraries to isolate antibodies of interest. Member of IACUC. Show less

Position required use of site-directed mutagenesis, synthesis and separation of ssDNA, PCR, plating and picking of bacterial colonies and sequence analysis.